Reevaluation and update on efficacy and safety of neostigmine for reversal of neuromuscular blockade
Jie Luo, Shuting Chen, Su Min, Lihua Peng Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China Abstract: Postoperative residual neuromuscular block is a serious threat which endangers the patient safety. Neostigmine has been the most...
Main Authors: | Luo J, Chen S, Min S, Peng L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-12-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/reevaluation-and-update-on-efficacy-and-safety-of-neostigmine-for-reve-peer-reviewed-article-TCRM |
Similar Items
-
Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications
by: Sung-Ae Cho, et al.
Published: (2022-04-01) -
Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review
by: Khawaja Rashid Hafeez, et al.
Published: (2018-07-01) -
Progress of residual neuromuscular blockade after general anesthesia in elderly patients
by: LIU Qiuli, et al.
Published: (2023-01-01) -
Influence of sugammadex versus neostigmine for neuromuscular block reversal on the incidence of postoperative pulmonary complications: a meta-analysis of randomized controlled trials
by: Jia-Feng Wang, et al.
Published: (2021-09-01) -
Effectiveness of partial and adjustment neostigmine dose as a neuromuscular reversal for single dose rocuronium
by: Jefferson Hidayat, et al.
Published: (2018-01-01)